|
Apr 8
|
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
|
|
Mar 27
|
Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
|
|
Jan 17
|
Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago
|
|
Dec 7
|
Are Medical Stocks Lagging Corvus Pharmaceuticals (CRVS) This Year?
|
|
Nov 12
|
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript
|
|
Nov 9
|
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
|
|
Nov 7
|
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
|
|
Nov 3
|
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
|
|
Nov 2
|
Cue Biopharma to Host Business Update Call and Webcast
|
|
Apr 25
|
Cue Biopharma Welcomes Seasoned Pharmaceutical Executive Pamela D. Garzone, Ph.D., to its Board of Directors
|